Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Yunnan Baiyao Group Co., (000538 CH)
Watchlist
65
Analysis
Health Care
•
China
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
29 May 2026 14:30
The Stocks to Own in China – Vol. 40
We highlight 10 stocks in China that look interesting to us based on our FVMR methodology. Portfolio changes: All 10 stocks have changed.
A. Stotz Investment Research
Follow
90 Views
Share
bullish
•
Thematic (Sector/Industry)
•
17 Apr 2026 19:46
The Stocks to Own in China – Vol. 39
We highlight 10 stocks in China that look interesting to us based on our FVMR methodology. Portfolio changes: Three stocks remain, seven new join...
A. Stotz Investment Research
Follow
146 Views
Share
bullish
•
Yunnan Baiyao Group Co.,
•
23 Sep 2025 10:50
•
Primer
Primer: Yunnan Baiyao Group Co., (000538 CH) - Sep 2025
Strong Brand Equity and Market Leadership: Yunnan Baiyao is a household name in China with a dominant position in the Traditional Chinese...
αSK
Follow
172 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Mar 2025 08:55
DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational
​DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...
Xinyao (Criss) Wang
Follow
388 Views
Share
bullish
•
Thematic (Sector/Industry)
•
17 Feb 2025 08:55
DeepSeek Ignites China Healthcare - The Investment Opportunities and Risks Behind
DeepSeek is revolutionizing the healthcare industry, but face data security issue and US restriction on cooperation with China.Companies...
Xinyao (Criss) Wang
Follow
659 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x